J&J secures extended NICE approval for Darzalex following earlier refusal
NICE has preliminarily recommended Darxalex-containing D-VRd for NHS use as a first-line treatment for transplant-ineligible multiple myeloma.
Read the full article on the original site.
Read Full Article